LONP1 alleviates ageing‐related renal fibrosis by maintaining mitochondrial homeostasis
Journal of Cellular and Molecular Medicine · 2024-09 · 28 (17)
DOI: 10.1111/jcmm.70090 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, online erschienen am 11.09.2024. Verfasst von Congxiao Zhang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Blood Purification Center, The Fourth People's Hospital of Shenyang, China Medical University, Shenyang, Liaoning, P. R. China. Hauptthemen laut MEDLINE: Mitochondria, Methyltransferases, Fibrosis, Aging. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Research Project of Health Commission in Shenyang.
Abstract (Originalsprache)
Mitochondrial dysfunction is a pivotal event contributing to the development of ageing‐related kidney disorders. Lon protease 1 (LONP1) has been reported to be responsible for ageing‐related renal fibrosis; however, the underlying mechanism(s) of LONP1‐driven kidney ageing with respect to mitochondrial disturbances remains to be further explored. The level of LONP1 was tested in the kidneys of aged humans and mice. Renal fibrosis and mitochondrial quality control were confirmed in the kidneys of aged mice. Effects of LONP1 silencing or overexpression on renal fibrosis and mitochondrial quality control were explored. In addition, N6‐methyladenosine (m6A) modification and methyltransferase like 3 (METTL3) levels, the relationship between LONP1 and METTL3, and the impacts of METTL3 overexpression on mitochondrial functions were confirmed. Furthermore, the expression of insulin‐like growth factor 2 mRNA binding protein 2 (IGF2BP2) and the regulatory effects of IGF2BP2 on LONP1 were confirmed in vitro. LONP1 expression was reduced in the kidneys of aged humans and mice, accompanied by renal fibrosis and mitochondrial dysregulation. Overexpression of LONP1 alleviated renal fibrosis and maintained mitochondrial homeostasis, while silencing of LONP1 had the opposite effect. Impaired METTL3‐m6A signalling contributed at least in part to ageing‐induced LONP1 modification, reducing subsequent degradation in an IGF2BP2‐dependent manner. Moreover, METTL3 overexpression alleviated proximal tubule cell injury, preserved mitochondrial stability, inhibited LONP1 degradation, and protected mitochondrial functions. LONP1 mediates mitochondrial function in kidney ageing and that targeting LONP1 may be a potential therapeutic strategy for improving ageing‐related renal fibrosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Blood Purification Center, The Fourth People's Hospital of Shenyang, China Medical University, Shenyang, Liaoning, P. R. China.
- Department of Anesthesiology, The Second Affiliated Hospital of Guangdong Medical University, Zhanjiang, Guangdong, P. R. China.
- Department of Laboratory Medicine, The Second Affiliated Hospital of Guangdong Medical University, Zhanjiang, Guangdong, P. R. China.
- Department of Nephrology, The First Affiliated Hospital of China Medical University, Shenyang, Liaoning, P. R. China.
ORCID-Profile: Xinwang Zhu
Förderung
- Research Project of Health Commission in Shenyang
Zitieren
APA
Zhang, C., Shen, S., Xu, L., Li, M., Tian, B., Yao, L., & Zhu, X. (2024). LONP1 alleviates ageing‐related renal fibrosis by maintaining mitochondrial homeostasis. Journal of Cellular and Molecular Medicine, 28(17). https://doi.org/10.1111/jcmm.70090
Vancouver
Zhang C, Shen S, Xu L, Li M, Tian B, Yao L, et al. LONP1 alleviates ageing‐related renal fibrosis by maintaining mitochondrial homeostasis. Journal of Cellular and Molecular Medicine. 2024;28(17). doi:10.1111/jcmm.70090
BibTeX
@article{Zhang2024,
author = {Zhang, Congxiao and Shen, Siman and Xu, Li and Li, Man and Tian, Binyao and Yao, Li and Zhu, Xinwang},
title = {LONP1 alleviates ageing‐related renal fibrosis by maintaining mitochondrial homeostasis},
journal = {Journal of Cellular and Molecular Medicine},
year = {2024},
volume = {28},
number = {17},
doi = {10.1111/jcmm.70090}
}
EUVIMED